|
创美药业股份有限公司 - H股, 02289.HK - 综合现金流量表 |
2022-12 |
2021-12 |
2020-12 |
2019-12 |
2018-12 |
2017-12 |
2016-12 |
2015-12 |
2014-12 |
2013-12 |
2012-12 |
经营活动之现金流量 |
80,067 |
17,878 |
158,007 |
43,212 |
89,871 |
3,557 |
-82,344 |
211,644 |
-6,511 |
51,426 |
66,914 |
投资回报及融资费用之现金流量 |
-28,440 |
-52,494 |
-56,512 |
-61,575 |
-48,360 |
-51,084 |
-34,404 |
-65,449 |
-18,099 |
-16,562 |
-16,554 |
已收利息 |
0 |
0 |
0 |
0 |
0 |
0 |
3,342 |
4,650 |
4,733 |
3,988 |
3,106 |
已付利息 |
0 |
0 |
0 |
0 |
0 |
0 |
-16,607 |
-24,099 |
-22,832 |
-20,550 |
-19,660 |
已收股息 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
已付股息 |
-28,440 |
-52,494 |
-56,512 |
-61,575 |
-48,360 |
-51,084 |
-21,139 |
-46,000 |
0 |
0 |
0 |
其他 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
退回/(已缴)税项 |
-36,017 |
-37,421 |
-26,931 |
-39,193 |
-40,720 |
-36,517 |
-18,540 |
-17,974 |
-8,315 |
-6,322 |
-5,214 |
投资活动之现金流量 |
71,762 |
-24,402 |
-54,780 |
-73,744 |
-97,569 |
-123,362 |
-34,177 |
-172,520 |
36,170 |
-65,693 |
-107,324 |
增添固定资产 |
-8,589 |
-25,040 |
-51,982 |
-73,903 |
-97,726 |
-125,625 |
-21,958 |
-30,311 |
-4,447 |
-5,104 |
-41,833 |
出售固定资产 |
80,351 |
638 |
58 |
160 |
157 |
177 |
158 |
30 |
681 |
220 |
5 |
投资增加 |
0 |
0 |
-2,856 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
投资减少 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
与关联人士之现金流量 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
其他 |
0 |
0 |
0 |
-1 |
0 |
2,086 |
-12,377 |
-142,239 |
39,936 |
-60,809 |
-65,496 |
融资活动前之现金流量 |
87,373 |
-96,439 |
19,785 |
-131,299 |
-96,778 |
-207,407 |
-169,465 |
-44,299 |
3,245 |
-37,151 |
-62,178 |
融资活动之现金流量 |
-162,772 |
126,895 |
53,836 |
115,701 |
77,520 |
164,702 |
133,406 |
177,632 |
2,290 |
41,566 |
61,514 |
新增贷款 |
825,887 |
957,971 |
950,409 |
784,884 |
692,100 |
750,400 |
457,362 |
312,650 |
264,850 |
271,270 |
265,314 |
偿还贷款 |
-1,070,916 |
-820,495 |
-884,997 |
-574,926 |
-671,300 |
-507,482 |
-326,650 |
-323,350 |
-263,060 |
-230,204 |
-204,300 |
定息/债项工具融资 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
偿还定息/债项工具 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
股本融资 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
188,332 |
0 |
0 |
0 |
与关联人士之现金流量 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
其他 |
82,257 |
-10,581 |
-11,576 |
-94,257 |
56,720 |
-78,216 |
2,694 |
0 |
500 |
500 |
500 |
现金及等同现金之增加/(减少) |
-75,399 |
30,455 |
73,621 |
-15,598 |
-19,258 |
-42,704 |
-36,059 |
133,333 |
5,535 |
4,415 |
-664 |
年初之现金及现金等同项目 |
144,227 |
113,771 |
40,149 |
55,739 |
75,097 |
119,569 |
155,629 |
22,296 |
16,761 |
12,346 |
13,010 |
外汇兑换率变动之影响/(其他) |
33 |
0 |
1 |
9 |
-101 |
-1,768 |
0 |
0 |
0 |
0 |
0 |
年终之现金及现金等同项目 |
68,861 |
144,227 |
113,771 |
40,149 |
55,739 |
75,097 |
119,570 |
155,629 |
22,296 |
16,761 |
12,346 |
货币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
单位 |
核数师意见 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
0 |
0 |
0 |
说明:1代表无保留意见;2代表保留意见;3代表修改意见
|
|